TY  - BOOK
AU  - Dressman,J.B.
AU  - Krämer,Johannes
AU  - Kra·mer,Johannes
TI  - Pharmaceutical dissolution testing
SN  - 9780824754679 (hbk.) :
AV  - RS189 .P446 2005
U1  - 615.19 DRE 
PY  - 2005///
CY  - New York, London
PB  - Marcel Dekker, Taylor & Francis [distributor]
KW  - Drugs
KW  - Solubility
KW  - Testing
KW  - Health and Wellbeing
KW  - ukslc
KW  - Pharmaceutical chemistry & technology
KW  - thema
N1  - Includes bibliographical references and index; 1.Historical development of dissolution testing -- 2.Compendium testing equipment: calibration, qualification, and sources of error -- 3.Compendial requirements of dissolution testing - European pharmacopoeia, Japanese pharmacopeia -- 4.The role of dissolution testing in the regulation of pharamceuticals: the FDA perspective -- 5.Gastrointestinal transit and drug absorption -- 6.Physiological parameters relevant to dissolution testing: hydrodynamic considerations -- 7.Development of dissolution tests on the basis of gastrointestinal physiology -- 8.Orally administered drug products: dissolution data analysis with a view to in vitro-in vivo correlation -- 9.Interpretation of in vitro-in vivo time profiles in terms of extent, rate and shape -- 10.Study design considerations for IVIVC -- 11.Dissolution method development with a view to quality control -- 12.Dissolution method development: an industry perspective -- 13.Design and qualification of automated dissolution systems 14.Bioavailability of ingredients in dietary supplements: a practical approach to the in vitro demonstration of the availability of ingredients in dietary supplements
N2  - This reference provides information on equipment, equipment qualification, consideration of the gastrointestinal physiology in test design and the analysis and interpretation of data and procedure automation
ER  -